Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Anderson

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
The Canadian Journal of Cardiology|October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The Canadian Journal of Cardiology|April 9, 2026
Author Correction to: "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology 41 (2025) 1857-1874]", Sean Virani, Shelley Zieroth, et al.
The Canadian Journal of Cardiology|January 1, 2026
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, October 2025, Pages 1857-1874. doi:10.1016/j.cjca.2025.07.027]Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The Canadian Journal of Cardiology|April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Sean Virani, Michael Chan, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
The Canadian Journal of Cardiology|October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The Canadian Journal of Cardiology|April 9, 2026
Author Correction to: "Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology 41 (2025) 1857-1874]", Sean Virani, Shelley Zieroth, et al.
The Canadian Journal of Cardiology|January 1, 2026
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, October 2025, Pages 1857-1874. doi:10.1016/j.cjca.2025.07.027]Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The Canadian Journal of Cardiology|April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Sean Virani, Michael Chan, et al.
Pageof 10